Practical implication
Identify and quarantine affected HeartWare batteries; follow manufacturer's instructions for battery management and replacement; ensure patients and healthcare providers are informed.
The Health Sciences Authority (HSA) of Singapore published a Field Safety Notice for HeartWare Ventricular Assist System batteries due to potential performance issues. Healthcare providers and patients are instructed to follow specific battery management and replacement instructions from the manufacturer.
What changed: HSA Singapore issued a Field Safety Notice for all HeartWare Ventricular Assist System batteries due to potential performance issues.
Why it matters: Battery performance issues in the HeartWare Ventricular Assist System could lead to device malfunction, posing serious risks to patients reliant on the system for cardiac support.
Practical implication: Identify and quarantine affected HeartWare batteries; follow manufacturer's instructions for battery management and replacement; ensure patients and healthcare providers are informed.
View original source
Published from the Firecrawl agent regulatory extraction pipeline.
